🇺🇸 FDA
Patent

US 8263762

Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists

granted A61PA61P13/12A61P17/00

Quick answer

US patent 8263762 (Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists) held by Dogwood Pharmaceuticals, Inc. expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Dogwood Pharmaceuticals, Inc.
Grant date
Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61P, A61P13/12, A61P17/00, A61P17/02, A61P19/06